Michael Cloonan

Chief Executive Officer presso Sionna Therapeutics, Inc.

53 anni

Health Technology

Consumer Services

Finance

Profilo

Michael Cloonan è direttore operativo di SAGE Therapeutics, Inc. In passato ha ricoperto la posizione di vicepresidente senior-US Commercial presso Biogen, Inc. Cloonan ha conseguito un MBA presso la University of Virginia Darden School of Business e una laurea presso il College of the Holy Cross (Massachusetts).

Posizioni attive di Michael Cloonan

Società	Posizione	Inizio
RA Capital Management LP (Private Equity) RA Capital Management LP (Private Equity) Investment ManagersFinance RA Capital Management LP (Private Equity) (RA Capital) is a private equity & venture capital subsidiary of RA Capital Management LP founded by Peter Kolchinsky in 2004. The firm is headquartered in Boston, MA.	Consultant / Advisor	-
Sionna Therapeutics, Inc. Sionna Therapeutics, Inc. Medical/Nursing ServicesHealth Services Sionna Therapeutics, Inc. is a clinical-stage life sciences company located in Natick, MA. The company is dedicated to developing highly effective and differentiated treatments for cystic fibrosis (CF) by normalizing the function of CFTR, the key protein associated with disease progression in CF. Sionna is advancing a pipeline of small molecules engineered to correct the protein defects caused by ?F508, the most common mutation that affects the CFTR protein. The company has a first-in-class portfolio of programs directly targeting correction of ?F508-CFTR, the key and unique mechanism to enable full restoration of ?F508-CFTR function, and complementary programs targeting ICL4 and more. The CEO of the company is Michael Cloonan.	Chief Executive Officer	-

Tutte le posizioni attive di Michael Cloonan

Precedenti posizioni note di Michael Cloonan

Società	Posizione	Fine
SAGE THERAPEUTICS, INC.	Chief Operating Officer	03/05/2021
BIOGEN INC.	Corporate Officer/Principal	01/01/2017

Vedi nel dettaglio l'esperienza di Michael Cloonan

Formazione di Michael Cloonan

College of the Holy Cross (Massachusetts)	Undergraduate Degree
University of Virginia Darden School of Business	Masters Business Admin

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Michael Cloonan

Relazioni

100 +

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	2
BIOGEN INC.	Health Technology
SAGE THERAPEUTICS, INC.	Health Technology

Aziende private	2
RA Capital Management LP (Private Equity) RA Capital Management LP (Private Equity) Investment ManagersFinance RA Capital Management LP (Private Equity) (RA Capital) is a private equity & venture capital subsidiary of RA Capital Management LP founded by Peter Kolchinsky in 2004. The firm is headquartered in Boston, MA.	Finance
Sionna Therapeutics, Inc. Sionna Therapeutics, Inc. Medical/Nursing ServicesHealth Services Sionna Therapeutics, Inc. is a clinical-stage life sciences company located in Natick, MA. The company is dedicated to developing highly effective and differentiated treatments for cystic fibrosis (CF) by normalizing the function of CFTR, the key protein associated with disease progression in CF. Sionna is advancing a pipeline of small molecules engineered to correct the protein defects caused by ?F508, the most common mutation that affects the CFTR protein. The company has a first-in-class portfolio of programs directly targeting correction of ?F508-CFTR, the key and unique mechanism to enable full restoration of ?F508-CFTR function, and complementary programs targeting ICL4 and more. The CEO of the company is Michael Cloonan.	Health Services